Press release
Beta Blockers Market Overview: Major Segments, Strategic Developments, and Leading Companies
Beta Blockers Market
Forecasted Market Expansion and Size of the Beta Blockers Market by 2030
The beta blockers market is projected to expand significantly, reaching a valuation of $13.96 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.6%. Several factors contribute to this upward trend, including progress in precision medicine, integration of digital health technologies, expansion into emerging markets, innovative drug delivery methods, and the adoption of personalized treatment strategies. Additionally, the increasing use of beta blockers for cardiovascular conditions, heightened awareness of preventive cardiac care, growth in hospital and retail pharmacy networks, development of new beta blocker formulations, and a rising elderly population suffering from hypertension and heart disorders are expected to fuel the market's advancement.
Download a free sample of the beta blockers market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10684&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Firms Driving the Beta Blockers Market Forward
The beta blockers market features a range of prominent companies shaping its development. Some of the key players include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca plc, Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Abbott Laboratories, Eagle Pharmaceuticals Inc., Neon Healthcare Ltd., Midas Pharma GmbH, AbbVie Inc., Mylan N.V., Boehringer Ingelheim International GmbH, Aspen Pharmacare Holdings Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Sandoz International GmbH, Wockhardt Ltd., Endo Pharmaceuticals Inc., and Apotex Inc.
Significant Acquisition Highlighting Market Expansion
In April 2023, Marksans Pharma, an Indian pharmaceutical firm, acquired a manufacturing facility from Teva Pharmaceutical Industries for an undisclosed amount. With this acquisition, Marksans Pharma aims to double its production capacity within India, strengthening its position as a leading cost-effective manufacturer while better meeting the increasing demand from its customer base. Teva Pharmaceutical Industries Ltd., based in Israel, is a multinational company specializing in the development, manufacturing, and commercialization of generic and specialty medicines.
View the full beta blockers market report:
https://www.thebusinessresearchcompany.com/report/beta-blockers-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends and Innovations in Beta Blockers
Companies within the beta blockers space are focusing heavily on introducing advanced beta-blocking agents specifically designed to treat severe hypertension and help reduce blood pressure. Beta blockers effectively manage high blood pressure by blocking peripheral arteriolar alpha-adrenoceptors, which lowers peripheral resistance, while simultaneous beta-blockade protects the heart from reflex sympathetic activity.
A recent example of innovation is Hikma Pharmaceuticals PLC, a UK-based company, which in March 2023 launched Labetalol Hydrochloride (Labetalol HCl) Injection, USP, in a prefilled syringe form in the US. This product targets severe hypertension and blood pressure reduction. Labetalol uniquely combines selective alpha1-adrenergic blocking with nonselective beta-adrenergic blocking actions, reducing peripheral resistance and lowering blood pressure. Classified as a non-selective beta-adrenergic receptor antagonist, it blocks both beta-1 and beta-2 receptors throughout the body.
Breakdown of Beta Blockers Market Segments
The beta blockers market is segmented based on several criteria:
By Type:
- Non-selective Agents
- Selective Agents
By Indication:
- Angina Pectoris
- Heart Failure
- High Blood Pressure
- Other Indications
By Drugs:
- Betaxolol
- Acebutolol
- Esmolol
- Other Drugs
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Application:
- Cardiac Diseases
- Hypertension
- Glaucoma
- Other Applications
Further detailed subsegments include:
Non-Selective Agents: Propranolol, Nadolol, Timolol
Selective Agents: Atenolol, Metoprolol, Bisoprolol, Nebivolol
This segmentation helps provide a comprehensive view of the market, catering to various therapeutic needs and distribution networks.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta Blockers Market Overview: Major Segments, Strategic Developments, and Leading Companies here
News-ID: 4495123 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Biodegradable Medical Polymers Ma …
The biodegradable medical polymers sector is positioned for significant expansion as demand for eco-friendly and advanced medical materials continues to rise. Innovations in polymer technologies and increasing applications in healthcare are driving this market forward. Let's explore the current market size, key factors influencing growth, important industry players, emerging trends, and segmentation within this evolving field.
Projected Market Size and Growth Rate of the Biodegradable Medical Polymers Market
The biodegradable…
Emerging Sub-Segments Transforming the Bacterial Cell Culture Market Landscape
The bacterial cell culture market is on track for significant expansion as it addresses critical needs across healthcare, biotechnology, and environmental sectors. Innovations and rising demand for faster, more reliable microbial testing methods are positioning this market for strong growth through 2030. Let's explore the market size projections, key players, emerging trends, and primary segments shaping this dynamic industry.
Projected Growth and Market Size of the Bacterial Cell Culture Market …
Top Firms and Competitive Dynamics in the Autoimmune Monoclonal Antibody Market
The autoimmune monoclonal antibody market is poised for substantial growth over the coming years, driven by advances in targeted therapies and personalized medicine. This sector is evolving rapidly as innovations in biotechnology and increased adoption of novel treatment methods pave the way for improved patient outcomes. Let's explore the current market size, key players, emerging trends, and detailed segment analysis shaping this dynamic market.
Projected Expansion and Market Size of the…
Market Driver Analysis: The Impact of Recent Innovations on the Suture Laparosco …
The suture laparoscopic forceps market is set to experience significant expansion in the coming years, driven by technological progress and evolving surgical practices. As minimally invasive procedures become more widespread, the demand for specialized surgical instruments like these forceps is increasing rapidly. Let's explore the market size, key players, driving factors, and the main segments shaping this industry's future.
Expected Growth Trajectory of the Suture Laparoscopic Forceps Market
The market…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
